ArticleIDCases2025
Neuromelioidosis in Rajasthan: A rare and fatal manifestation of
Article in IDCases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Severe acute respiratory distress syndrome due toIDCases · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Melioidosis, an often-fatal infection caused by Case Presentation: A 65-year-old male with a background of chronic obstructive pulmonary disease (COPD) presented with prolonged fever, respiratory symptoms, and altered mental status. Neurological examination revealed increased limb tone and extensor plantar responses. Imaging revealed subcortical white matter hypodensity and multiple centrilobular nodules. Initial cerebrospinal fluid (CSF) analysis was suggestive of tubercular meningitis; however, subsequent blood and CSF cultures confirmed Discussion: Neuromelioidosis remains a diagnostic challenge due to its ability to mimic other CNS infections, particularly tuberculosis. This case underscores the critical role of microbiological confirmation in guiding treatment. While the standard treatment protocol includes an intensive phase with meropenem followed by maintenance with trimethoprim-sulfamethoxazole, delays in diagnosis significantly worsen outcomes. Conclusion: Clinicians should maintain a high index of suspicion for neuromelioidosis in patients with unexplained neurological symptoms, even in non-endemic, arid regions like Rajasthan. Timely diagnosis and targeted therapy are key to improving prognosis. This case highlights the need for greater awareness and diagnostic vigilance in atypical geographic settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.